Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver

Clinical and Experimental Metastasis

Volumn 17, Issue 4, 1999, Pages 283-291

  Ogasawara, Masaru ^a   Murata, Jun ^a   Kamitani, Yukio ^a   Hayashi, Kazuko ^a   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Angiogenesis; Colon carcinoma; Metastasis; Motility; VIP

Indexed keywords

CYCLIC AMP; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; LIVER METASTASIS; MORPHOGENESIS; MOUSE; NONHUMAN;

ANIMALS; COLLAGEN; COLONIC NEOPLASMS; CYCLIC AMP; DRUG COMBINATIONS; ENDOPEPTIDASES; EXTRACELLULAR MATRIX; LAMININ; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0032833049     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006648402164     Document Type: Article

References (46)

1. Folkman J, Cotran, Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 1976; 16: 207-48.
2. Folkman J, How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial award lecture. Cancer Res 1986; 46: 467-73.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267:10931-4.
4. O'Reilly MS, Holmgren L, Shing Y et al. Angiostatin: a novel angiogenesis inhibitor that mediate the suppression of metastases by a lewis lung carcinoma. Cell 1994; 79:315-28.
5. Weinstat-Saslow DL, Zabrenetzky VS, VanHoutte K et al. Transfection of thrombospondin I complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res 1994; 54:6504-11.
6. Kolber DL, Knisely TL, Maione TE. Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4. J Natl Cancer Inst 1995; 87: 304-9.
7. Arenberg DA, Kunkol SL, Polverini PJ et al. Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small call lung cancer (NSCLC) tumorigenesis and spontaneous metastases. J Exp Med 1996; 184: 981-92.
8. O'Reilly MS, Boehm T, Shing Y et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
9. Dinney CPN, Bielenberg DR, Perrote P et al. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human carcinoma in mice by systemic interferon-alpha administration. Cancer Res 1998; 58: 808-14.
10. Xie K, Fidler IJ. Therapy of cancer metastasis by activation of the inducible nitric oxide synthetase. Cancer Metastasis Rev 1998; 17: 55-75.
11. Said SJ, Mutt V. Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature 1970; 225: 863-4.
12. Said SI, Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 1970; 169: 1217-8.
13. Giachetti A, Said SL, Reynolds RC, Koniges FC. Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci USA 1977; 74: 3424-8.
14. Krejs GJ, Fordtran JS, Bloom SR et al. Effect of VIP infusion on water and ion transport in the human jejunum. Gastroenterology 1980; 78: 722-7.
15. Itoh H, Lederis KP, Rorstad OP. Relaxation of isolated bovine coronary arteries by vasoactive intestinal peptide. Eur J Pharmacol 1990; 18: 199-205.
16. Ahren B, Alumets J, Ericsson M et al. VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretion, Nature 1980; 287: 343-5.
17. Johnston JA, Tauh DD, Lloyd AR et al. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J Immunol 1994; 153: 1762-8.
18. Ishioka C, Yoshida A, Kimata H, Mikawa H. Vasoactive intestinal peptide, stimulates immunoglobulin production and growth of human B cells. Clin Exp Immunol 1992; 87: 504-8.
19. Ogasawara M, Murata J, Ayukawa K, Saiki I. Differential effect of intestinal neuropeptides on invasion and migration of colon carcinoma cells in vitro. Cancer Lett 1997; 116: 111-6.
20. Oasawara M, Murata J, Ayukawa K, Saiki I. Inhibitory effect of vasoactive intestinal polypeptide (VIP) on experimental liver metastasis by murine Colon 26-L5 carcinoma cells. Oncol Res 1998; 10:361-70.
21. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulalion. Cell 1991: 64:327-36.
22. Ohnishi Y, Sakamoto T, Fujii H et al. Characterization of a liver metastatic variant of murine Colon 26 carcinoma cells, Tumor Biol 1997; 18: 113-22.
23. Weidner N, Semple JP, Weleh WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
24. Saiki I, Murata J, Watanabe K et al. Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro. Jpn J Cancer Res 1989: 80: 873-8.
25. Ala N, Oku T, Hattori M et al. Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degaradation of type IV collagens by metastatic tumor cells. Oncol Res 1996; 8: 503-11.
26. Cid MC, Grant DS, Hoffman GS et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993; 91: 977-85.
27. Tanigawa N, Lu C, Mitsui T, Miura S. Quantification of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology 1997; 26: 1216-23.
28. Heussen C, Dowdle EB, Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and co-polymerized substrates. Anal Biochem 1980; 102:196-202.
29. Sreedharan SP, Robichon A, Peterson KE, Goetzl EJ. Cloning and expression of the human vasoactive intestinal peptide receptor. Proc Natl Acad Sci USA 1991; 88: 4986-90.
30. Lampugnani MG, Giorgi M, Gaboli M et al. Endothelial cell motility, integrin receptor clustering, and microfilament organization are inhibited by agents that increase intracellular cAMP. Lab Invest 1990; 63: 521-31.
31. Dong J-M, Leung T, Manser E, Lim L. cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKα. J Biol Chem 1998; 273: 22554-62.
32. Lang P, Gesbert F, Delespine-Carmagnat M et al. Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cytotoxic lymphocytes. EMBO J 1996; 15:510-9.
33. Singh RK, Tsan R, Radinsky R. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin Exp Metastasis 1997; 15: 140-50.
34. Liotta, LA. Tumor invasion and metastases - role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res 1986; 46: 1-7.
35. Villablanca AC, Murphy CJ, Reid TW. Growth-promoting effects of substance P on endothelial cells in vitro: synergism with calcitonin gene-related peptide, insulin, and plasma factors. Circ Res, 1994; 75: 1113-20.
36. Zukowska-Grojec Z, Karwatowska-Prokopezuk E, Rose W et al. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res 1998; 83: 187-95.
37. Barrie R. Woltering EA, Hajarizadeh H et al. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J Surg Res 1993: 55: 446-50.
38. Woltering EA, Barrie R, O'Dorisio TM et al. Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J Surg Res 1991; 50: 245-51.
39. Qin Y, Cauteren MV, Osteaux M et al. Inhibitory effect of somatostatin analogue RC-160 on the growth of hepatic metastases of colon cancer in rats: a study with magnetic resonance. Cancer Res 1992; 52: 6025-30.
40. Hegerstrand A, Dalsgaard C-J, Jonzon B et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. Proc Natl Acad Sci USA 1990; 87: 3299-303.
41. Kahler CM, Kirchmair, R, Kaufmann G et al. Inhibition of proliferation and stimulation of migration of endothelial cells by secretoneurin in vitro. Arterioselerosis, Thromb Vase Biol 1997; 17: 932-9.
42. Staren ED, Gould VE, Jansson DS et al. Neuroendocrine differentiation in poorly differentiated colon carcinomas. Am Surg 1990; 56: 412-9.
43. Noordzij MA, van Steenbrugge GJ, van der Kwast TH et al. Neuroendocrine cells in the normal, hyperplastic and neoplastic prostate. Urol Res 1995; 22:333-41.
44. de Bruine AP, Wiggers T, Beck C et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer 1993; 54: 765-71.
45. Ghanem G, Lienard D, Hanson P et al. Increased serum alphamelanocyte stimulating hormone (alpha-MSH) in human malignant melanoma. Eur J Cancer Clin Oncol 1986; 22: 535-6.
46. Frucht H, Gazdar AF, Park J-A et al. Characterization of functional receptors for gastrointestinal hormones on human colon cancer cells. Cancer Res 1992; 52:1114-22.